Development of xenoimplants from germline BRCA1/2 mutant breast cancer (BC) for the identification of predictive biomarkers, mechanisms of resistance against poly(ADP-ribose) polymerase (PARP) inhibitors and evaluation of novel therapies Meeting Abstract


Authors: Cruz, C.; Ibrahim, Y.; Morancho, B.; Antón, P.; Grueso, J.; Cozar, P.; Guzman, M.; Aviles, P. M.; Guillen, M. J.; Galmarini, C.; Arribas, J.; Baselga, J.; Balmana, J.; Serra, V.
Abstract Title: Development of xenoimplants from germline BRCA1/2 mutant breast cancer (BC) for the identification of predictive biomarkers, mechanisms of resistance against poly(ADP-ribose) polymerase (PARP) inhibitors and evaluation of novel therapies
Meeting Title: 26th EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics
Journal Title: European Journal of Cancer
Volume: 50
Issue: Suppl. 6
Meeting Dates: 2014 Nov 18-21
Meeting Location: Barcelona, Spain
ISSN: 0959-8049
Publisher: Elsevier Inc.  
Date Published: 2014-11-01
Start Page: 82
Language: English
ACCESSION: WOS:000347755700245
PROVIDER: wos
DOI: 10.1016/S0959-8049(14)70370-3
Notes: Meeting Abstract: 244 -- 26th EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics -- NOV 18-21, 2014 -- Barcelona, SPAIN -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Jose T Baselga
    484 Baselga